Virpax Pharmaceuticals (VRPX) Earnings Date & Reports
A.I. Advisor
published Earnings
VRPX is expected to report earnings to rise 488.24% to -300 cents per share on March 28
Q4'23
Est.
$-3.00
Q3'23
Missed
by $0.25
Q2'23
Missed
by $2.54
Q1'23
Beat
by $0.17
Q4'22
Missed
by $1.93
The last earnings report on November 15 showed earnings per share of -50 cents, missing the estimate of -25 cents. With 7.50K shares outstanding, the current market capitalization sits at 3.31M.